Skip to main content

Iron protein succinylate Disease Interactions

There are 2 disease interactions with iron protein succinylate.

Major

Ferrous salts (applies to iron protein succinylate) hemoglobin abnormalities

Major Potential Hazard, Moderate plausibility. Applicable conditions: Blood Transfusion, Hemoglobinopathy

There is no excretory mechanism for iron. Iron will correct only hemoglobin abnormalities due to iron deficiency and should not be used to treat conditions such as thalassemia, hemosiderosis, hemochromatosis, normocytic anemia (unless iron deficiency exists), or in patients receiving blood transfusions. Clinical monitoring of erythropoietic function and ferritin levels is recommended.

References

  1. "Product Information. Infed (iron dextran)." Schein Pharmaceuticals Inc
  2. (2001) "Product Information. Venofer (iron sucrose)." American Regent Laboratories Inc
Moderate

Iron products (applies to iron protein succinylate) ulcers

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Peptic Ulcer, Inflammatory Bowel Disease, Achlorhydria

Iron replacement therapy should be used cautiously in patients with peptic ulcer disease, regional enteritis, or ulcerative colitis, as these patients may have poor absorption of oral iron supplements.

References

  1. (2005) "Product Information. Ferretts IPS (iron protein succinylate)." Pharmics Inc

Iron protein succinylate drug interactions

There are 87 drug interactions with iron protein succinylate.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer